We Can Now Drive Aging Forward and Backward at Will — Here's What That Means | Impact Theory W. Tom Bilyeu Dr. David Sinclair
Dr. David Sinclair discusses his lab's groundbreaking research on age reversal, including brain organoids, nerve regrowth, and a three-chemical cocktail that can rejuvenate cells. He explains how OSK gene introduction can reverse aging in eyes, brains, and other tissues, with human clinical trials imminent. He also shares his personal health protocols including NMN, resveratrol, berberine, and lifestyle recommendations.
Summary
Dr. David Sinclair discusses a wide range of cutting-edge aging research happening in his Harvard lab, beginning with brain organoids — miniature brains grown from stem cells that model aging in real time. These organoids display reduced neural firing as they age (visible via calcium-sensitive dyes), and when treated with a three-chemical cocktail or OSK genes, their neural activity is restored. Similar organoid models are being developed for uteruses and skin, with the goal of reversing reproductive aging and testing fertility restoration. NAD supplementation has already shown promising results in a small human trial, producing two-to-threefold improvements in egg count and quality in women with fertility challenges.
Sinclair's most significant claim centers on nerve regrowth — something long considered biologically impossible. His lab achieved 100% regrowth of crushed optic nerves in mice using OSK gene introduction, restoring sight in animals made blind by laser damage. This approach is now being tested in glaucoma patients in clinical trials. The same mechanism has shown promise for ALS-related nerve-muscle junction degeneration and potentially spinal cord injuries. Sinclair estimates an 80-90% probability that this technology will work in humans, based on successful monkey trials.
The OSK system works by delivering three genes (Oct4, Sox2, Klf4) via a one-time injection, then activating them periodically using doxycycline (a common antibiotic). This resets the epigenetic 'methylation' patterns in cells — essentially restoring the informational backup copy of youthful gene expression. Sinclair explains aging as primarily an information loss problem: cells forget how to read their own DNA correctly, and OSK re-teaches them. He distinguishes between reversible epigenetic changes (which his technology addresses) and irreversible genetic mutations (which remain a harder challenge for true immortality).
Sinclair's lab is also developing a consumer-facing product line through a company called Paradigm 88 (co-founded with his partner Serena). These products aim to use natural molecules — likely including some already in the human food supply — to activate the same rejuvenation pathways, potentially improving skin, hair color, and overall vitality within weeks. Mouse trials showed measurable improvements in strength, memory, and balance after just four weeks of oral treatment. He intentionally avoids naming the specific molecules to prevent unvetted self-experimentation.
On personal health protocols, Sinclair takes NMN (1g/day), resveratrol (1g/day mixed with yogurt or olive oil for absorption), and berberine as a glucose-lowering supplement. He has cardiovascular risk due to his Ashkenazi Jewish heritage and has been on a statin since age 29. He recently added natokinase and niacin (half a gram) to address LP(a) levels — a lipoprotein marker he considers an underappreciated cardiovascular risk factor. He eats a 95% plant-based diet, practices intermittent fasting, avoids alcohol, drinks matcha daily, and uses ketone supplements before cognitively demanding tasks.
Sinclair also disclosed that he recently had a non-melanoma skin cancer removed from his face despite lifelong sun avoidance, attributing possible genetic susceptibility. He recommends annual full-body MRIs, carotid ultrasounds, liquid biopsy cancer blood tests, and genome sequencing for proactive health monitoring. He warns against sugar (framing it as a long-term toxin that glycates proteins), sedentary behavior, smoking, and chronic stress. He emphasizes the importance of deep sleep for clearing Alzheimer's-associated proteins from the brain, and has adopted breathing practices and scheduled relaxation to manage stress. His Lifespan podcast is relaunching and his lab now accepts public donations at friendsofsinclairlab.org.
Key Insights
- Sinclair's lab grew brain organoids from stem cells that visibly age over time, showing reduced calcium-based neural firing — and this firing can be restored with a three-chemical cocktail, demonstrating reversible aging in neural tissue.
- Sinclair's team achieved 100% regrowth of laser-destroyed optic nerves in monkeys using OSK gene introduction, a result he says far exceeds prior research that achieved only ~5% nerve regrowth.
- Sinclair argues that the OSK system doesn't merely slow aging but actively rebuilds tissue to a younger state — including clearing protein inclusions like lipofuscin in the retina, which he did not expect.
- Sinclair describes aging as fundamentally an information loss problem: epigenetic 'methylation' patterns degrade over time, and OSK works by restoring a backup copy of youthful cellular instructions rather than fixing DNA mutations.
- Sinclair states that amyloid plaque clearance may not be necessary for Alzheimer's improvement — his mouse models recovered memory function without plaque removal, suggesting the epigenetic dysfunction is a more primary driver.
- A small but rigorous human clinical trial showed a two-to-threefold improvement in egg count and embryo quality in women who received weekly NAD IVs for 10 weeks, which Sinclair describes as 'extremely promising' though preliminary.
- Sinclair plans to launch consumer products through Paradigm 88 using natural molecules that activate the same rejuvenation pathways as his pharmaceutical-grade OSK system, with skin and hair restoration as early target applications.
- Sinclair argues that resveratrol must be dissolved in fat (olive oil or yogurt) to achieve meaningful absorption — he claims clinical trials that delivered it in water likely failed partly for this reason.
- Sinclair identified LP(a) — a lipoprotein rarely tested in standard panels — as a significant cardiovascular risk marker in his own bloodwork, prompting him to increase his statin dose and add niacin supplementation.
- Sinclair claims that the OSK treatment system requires only a single gene-introduction shot followed by periodic doxycycline doses to re-activate the rejuvenation genes, rather than repeated gene therapy injections.
- Sinclair argues that children today are aging faster than previous generations due to poor diet, and that epigenetic patterns laid down during teenage years can have health consequences decades later.
- Sinclair contends that a fundamental barrier to true immortality is not epigenetic decay (which he believes is largely reversible) but irreversible genetic information loss in individual cells, which cannot yet be corrected at scale.
Topics
Full transcript available for MurmurCast members
Sign Up to Access